Cingulate Inc.

NASDAQ (USD): Cingulate Inc. (CING)

Last Price

4.36

Today's Change

-0.11 (2.46%)

Day's Change

4.31 - 4.53

Trading Volume

77,096

Overview

Market Cap

14 Million

Shares Outstanding

3 Million

Avg Volume

158,155

Avg Price (50 Days)

4.58

Avg Price (200 Days)

5.95

PE Ratio

-0.10

EPS

-43.22

Earnings Announcement

07-Mar-2025

Previous Close

4.47

Open

4.47

Day's Range

4.31 - 4.53

Year Range

1.8 - 20.83

Trading Volume

77,455

Price Change Highlight

1 Day Change

-2.46%

5 Day Change

-2.90%

1 Month Change

-9.36%

3 Month Change

25.65%

6 Month Change

78.69%

Ytd Change

-14.51%

1 Year Change

-67.56%

3 Year Change

-98.89%

5 Year Change

-99.59%

10 Year Change

-99.59%

Max Change

-99.59%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment